Skip to main content
Premium Trial:

Request an Annual Quote

VBI Teams With Brazilian Institute to Develop Infectious Disease Products

NEW YORK, May 3 (GenomeWeb News) - The Virginia Bioinformatics Institute and a Brazilian health institute yesterday said they plan to develop a wide range of medical products and technologies.


The initial three-year alliance calls for the VBI and the Oswaldo Cruz Foundation to "facilitate the development of" drugs, vaccines, diagnostics, and "other technologies" for infectious diseases, including dengue fever, hepatitis C, HIV/AIDS, influenza, malaria, and pneumonia.


Details of the agreement were not disclosed.


FIOCRUZ, based in Rio de Janeiro, has expertise in biology, medicine, and the epidemiology of infectious diseases, while VBI is known for its genomics, proteomics, and bioinformatics tools and data.

The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.